Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Drug interactions for low dose inhaled nemiralisib - a case study integrating modelling, in vitro and clinical investigations.

Patel A, Wilson R, Harrell AW, Taskar KS, Taylor M, Tracey H, Riddell K, Georgiou A, Cahn AP, Marotti M, Hessel EM.

Drug Metab Dispos. 2020 Feb 2. pii: dmd.119.089003. doi: 10.1124/dmd.119.089003. [Epub ahead of print]

2.

An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects.

Harrell AW, Wilson R, Man YL, Riddell K, Jarvis E, Young G, Chambers R, Crossman L, Georgiou A, Pereira A, Kenworthy D, Beaumont C, Marotti M, Wilkes D, Hessel EM, Fahy WA.

Drug Metab Dispos. 2019 Dec;47(12):1457-1468. doi: 10.1124/dmd.119.088344. Epub 2019 Oct 24.

PMID:
31649125
3.

Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase δ Inhibitor.

Begg M, Edwards CD, Hamblin JN, Pefani E, Wilson R, Gilbert J, Vitulli G, Mallett D, Morrell J, Hingle MI, Uddin S, Ehtesham F, Marotti M, Harrell A, Newman CF, Fernando D, Clark J, Cahn A, Hessel EM.

J Pharmacol Exp Ther. 2019 Jun;369(3):443-453. doi: 10.1124/jpet.119.257311. Epub 2019 Apr 2.

PMID:
30940692
4.

ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.

Wu YL, Herbst RS, Mann H, Rukazenkov Y, Marotti M, Tsuboi M.

Clin Lung Cancer. 2018 Jul;19(4):e533-e536. doi: 10.1016/j.cllc.2018.04.004. Epub 2018 May 1.

5.

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC, Cheng Y, Cho EK, Voon PJ, Planchard D, Su WC, Gray JE, Lee SM, Hodge R, Marotti M, Rukazenkov Y, Ramalingam SS; FLAURA Investigators.

N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18.

6.

A retrospective study of isolated fractures of the alveolar process in the permanent dentition.

Marotti M, Ebeleseder KA, Schwantzer G, Jauk S.

Dent Traumatol. 2017 Jun;33(3):165-174. doi: 10.1111/edt.12325. Epub 2017 Apr 5.

PMID:
28177588
7.

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators.

N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6.

8.

Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma.

Judson I, Scurr M, Gardner K, Barquin E, Marotti M, Collins B, Young H, Jürgensmeier JM, Leahy M.

Clin Cancer Res. 2014 Jul 1;20(13):3603-12. doi: 10.1158/1078-0432.CCR-13-1881. Epub 2014 Apr 8.

9.

Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.

Zokalj I, Marotti M, Kolarić B.

Int Urol Nephrol. 2014 Jun;46(6):1089-100. doi: 10.1007/s11255-013-0631-8. Epub 2014 Jan 1.

PMID:
24381132
10.

Multiphase computed tomography of malignant kidney tumors: radiologic-pathologic comparison.

Zokalj I, Marotti M, Saghir H, Gasparov S, Kolarić B, Plesnar A.

Acta Clin Croat. 2012 Dec;51(4):563-71.

PMID:
23540164
11.

Temporomandibular disorders and occlusion.

Badel T, Marotti M, Pavicin IS, Basić-Kes V.

Acta Clin Croat. 2012 Sep;51(3):419-24. Review.

PMID:
23339268
12.

Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment.

van Herpen CM, Lassen U, Desar IM, Brown KH, Marotti M, de Jonge MJ.

Anticancer Drugs. 2013 Feb;24(2):204-11. doi: 10.1097/CAD.0b013e32835bd1d2.

PMID:
23197081
13.

Radiographic validation of manual functional analysis of temporomandibular joint osteoarthritis.

Badel T, Marotti M, Savić-Pavicin I, Zadravec D, Kern J.

Acta Clin Croat. 2012 Mar;51(1):35-42.

PMID:
22924180
14.

Severe cutaneous adverse reactions (SCAR) syndromes.

Marotti M.

Rev Assoc Med Bras (1992). 2012 May-Jun;58(3):276-8. No abstract available.

15.

Stabilization splint treatment on complete denture--two reported cases.

Badel T, Jerolimov V, Marotti M, Krolo I.

Eur J Prosthodont Restor Dent. 2012 Mar;20(1):17-21.

PMID:
22474931
16.

Correlation between magnetic resonance imaging and histopathology in differentiation of pancreatic diseases.

Sverko A, Tripalo-Batos A, Marotti M, Mustapić M, Beslin MB, Kruslin B.

Acta Clin Croat. 2011 Jun;50(2):137-44.

PMID:
22263375
17.

Temporomandibular joint development and functional disorders related to clinical otologic symptomatology.

Badel T, Savić-Pavicin I, Zadravec D, Marotti M, Krolo I, Grbesa D.

Acta Clin Croat. 2011 Mar;50(1):51-60.

PMID:
22034784
18.

Primum non nocere: authors or reviewers?

Marotti M.

Rev Assoc Med Bras (1992). 2011 Sep-Oct;57(5):477, 487. English, Portuguese. No abstract available.

19.

Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours.

Trarbach T, Schultheis B, Gauler TC, Schneider V, Strumberg D, Eberhardt WE, Le Scouiller S, Marotti M, Brown KH, Drevs J.

Invest New Drugs. 2012 Oct;30(5):1962-71. doi: 10.1007/s10637-011-9754-x. Epub 2011 Oct 12.

PMID:
21989836
20.

Study of temporomandibular joint disorder in older patients by magnetic resonance imaging.

Badel T, Simunković SK, Marotti M, Lovko SK, Kern J, Krolo I.

Gerodontology. 2012 Jun;29(2):e735-41. doi: 10.1111/j.1741-2358.2011.00552.x. Epub 2011 Sep 14.

PMID:
21916955
21.

Superoxide dismutase and cytochrome P450 isoenzymes might be associated with higher risk of renal cell carcinoma in male patients.

Sverko A, Sobočanec S, Kušić B, Mačak-Šafranko Z, Sarić A, Leniček T, Kraus O, Andrišić L, Korolija M, Balog T, Sunjić SB, Marotti M.

Int Immunopharmacol. 2011 Jun;11(6):639-45. doi: 10.1016/j.intimp.2010.12.023. Epub 2011 Jan 14.

PMID:
21238623
22.

Preoperative staging of renal cell carcinoma using magnetic resonance imaging: comparison with pathological staging.

Spero M, Brkljacic B, Kolaric B, Marotti M.

Clin Imaging. 2010 Nov-Dec;34(6):441-7. doi: 10.1016/j.clinimag.2009.09.005.

PMID:
21092873
23.

A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.

Fox E, Aplenc R, Bagatell R, Chuk MK, Dombi E, Goodspeed W, Goodwin A, Kromplewski M, Jayaprakash N, Marotti M, Brown KH, Wenrich B, Adamson PC, Widemann BC, Balis FM.

J Clin Oncol. 2010 Dec 10;28(35):5174-81. doi: 10.1200/JCO.2010.30.9674. Epub 2010 Nov 8.

24.

Magnetic resonance imaging in the diagnosis of malignant tumors of the maxillofacial region.

Podoreski D, Krolo I, Ivkić M, Marotti M, Kosović V, Visković K.

Acta Clin Croat. 2010 Mar;49(1):33-41.

PMID:
20635582
25.

Thiophene occurrence in different Tagetes species: agricultural biomasses as sources of biocidal substances.

Marotti I, Marotti M, Piccaglia R, Nastri A, Grandi S, Dinelli G.

J Sci Food Agric. 2010 May;90(7):1210-7. doi: 10.1002/jsfa.3950.

PMID:
20394003
26.

[What is the role of the physician in assessing drug safety?].

Marotti M.

Rev Assoc Med Bras (1992). 2010 Jan-Feb;56(1):4-5. Portuguese. No abstract available.

27.

[Why review answer criteria in solid tumors ?].

Marotti M.

Rev Assoc Med Bras (1992). 2009 Jul-Aug;55(4):369-71. Portuguese. No abstract available. Erratum in: Rev Assoc Med Bras. 2009 Sep-Oct;55(5):509.

28.

Magnetic resonance imaging study on temporomandibular joint morphology.

Badel T, Marotti M, Keros J, Kern J, Krolo I.

Coll Antropol. 2009 Jun;33(2):455-60.

PMID:
19662763
29.

[Metric analysis of temporomandibular joint in asymptomatic persons by magnetic resonance imaging].

Badel T, Pandurić J, Marotti M, Kern J, Krolo I.

Acta Med Croatica. 2008 Dec;62(5):455-60. Croatian.

PMID:
19382627
30.

A quantitative analysis of splint therapy of displaced temporomandibular joint disc.

Badel T, Marotti M, Kern J, Laskarin M.

Ann Anat. 2009 Jun;191(3):280-7. doi: 10.1016/j.aanat.2008.12.004. Epub 2009 Feb 12.

PMID:
19282162
31.

Occlusion in patients with temporomandibular joint anterior disk displacement.

Badel T, Marotti M, Krolo I, Kern J, Keros J.

Acta Clin Croat. 2008 Sep;47(3):129-36.

PMID:
19175060
32.

Comparison of A-scan and MRI for the measurement of axial length in silicone oil-filled eyes.

Bencic G, Vatavuk Z, Marotti M, Loncar VL, Petric I, Andrijevic-Derk B, Skunca J, Mandic Z.

Br J Ophthalmol. 2009 Apr;93(4):502-5. doi: 10.1136/bjo.2008.147868. Epub 2008 Dec 15.

PMID:
19074920
33.

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases.

Ming EE, Davidson MH, Gandhi SK, Marotti M, Miles CG, Ke X, McKenney JM.

J Clin Lipidol. 2008 Dec;2(6):453-63. doi: 10.1016/j.jacl.2008.10.007. Epub 2008 Oct 28.

PMID:
21291779
34.

[Why create a exclusive law for the development of drugs in pediatrics?].

Marotti M.

Rev Assoc Med Bras (1992). 2008 Mar-Apr;54(2):98-9. Portuguese. No abstract available.

35.

[What are the clinical objectives that determine the effectiveness of treatments in oncology?].

Marotti M.

Rev Assoc Med Bras (1992). 2007 Nov-Dec;53(6):477-8. Portuguese. No abstract available.

36.

MR assessment of bile duct size in healthy individuals: comparison with US measurements.

Prpić GL, Babić N, Marjan D, Pećina M, Marotti M.

Coll Antropol. 2007 Jun;31(2):567-71.

PMID:
17847941
37.

[When do we report drug adverse reactions in clinical trials? ].

Marotti M.

Rev Assoc Med Bras (1992). 2007 Jul-Aug;53(4):285-6. Portuguese. No abstract available.

38.

The risk of sports activities--the injuries of the Achilles tendon in sportsmen.

Krolo I, Visković K, Ikić D, Klarić-Custović R, Marotti M, Cicvara T.

Coll Antropol. 2007 Mar;31(1):275-8.

PMID:
17598413
39.

[Initial treatment of temporomandibular joint osteoarthritis].

Badel T, Pandurić J, Marotti M, Lovko SK, Krolo I.

Reumatizam. 2006;53(1):29-32. Croatian.

PMID:
17580547
40.

Using magnetic resonance imaging to identify the lumbosacral segment in children.

Milicić G, Krolo I, Vrdoljak J, Marotti M, Roić G, Hat J.

Coll Antropol. 2006 Mar;30(1):55-8.

PMID:
16617576
41.

The influence of season on oxidant-antioxidant status in trained and sedentary subjects.

Balog T, Sobocanec S, Sverko V, Krolo I, Rocić B, Marotti M, Marotti T.

Life Sci. 2006 Feb 23;78(13):1441-7. Epub 2005 Oct 19.

PMID:
16242733
42.

[Spiral CT angiography in practice].

Pavcec Z, Zokalj I, Rumboldt Z, Pal A, Saghir H, Ozretić D, Latin B, Perhoć Z, Marotti M.

Lijec Vjesn. 2005 Jan-Feb;127(1-2):24-9. Croatian.

PMID:
16145870
43.

The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.

Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M; DISCOVERY PENTA investigators.

Curr Med Res Opin. 2005 Aug;21(8):1307-15.

PMID:
16083541
44.

Subarachnoid haemorrhage headache from a developmental venous anomaly.

Lovrencic-Huzjan A, Rumboldt Z, Marotti M, Demarin V.

Cephalalgia. 2004 Sep;24(9):763-6. No abstract available.

PMID:
15315533
45.

Retained surgical textilomas occur more often during war.

Klarić Custović R, Krolo I, Marotti M, Babić N, Karapanda N.

Croat Med J. 2004 Aug;45(4):422-6.

46.

Long-term survival after recurrent retinoblastoma and second malignancy with massive lung metastasis.

Hajnzic TF, Marotti M, Vrsalovic R.

Eur J Pediatr. 2004 Nov;163(11):685-6. Epub 2004 Aug 7. No abstract available.

PMID:
15309622
47.

Preprosthetic therapy utilizing a temporary occlusal acrylic splint: a case report.

Badel T, Kraljeviç S, Panduriç J, Marotti M.

Quintessence Int. 2004 May;35(5):401-5.

PMID:
15130082
48.

Magnetization transfer, HASTE, and FLAIR imaging.

Rumboldt Z, Marotti M.

Magn Reson Imaging Clin N Am. 2003 Aug;11(3):471-92. Review.

PMID:
14768730
49.

The advancement in the early diagnostics of developmental hip dysplasia in infants--the role of ultrasound screening.

Krolo I, Visković K, Kozić S, Marotti M, Klarić-Custović R, Banak-Zahtila N, Ikić D, Premate-Milas L.

Coll Antropol. 2003 Dec;27(2):627-34.

PMID:
14746152
50.

Enkephalin degradating enzymes in pheochromocytoma patients.

Balog T, Marotti T, Sverko V, Marotti M, Krolo I, Rocic B, Karapanda N.

Oncol Rep. 2003 Jan-Feb;10(1):253-8.

PMID:
12469178

Supplemental Content

Loading ...
Support Center